Tuberculosis

Featured

TBWEB

Tuberculosis R&D “grossly insufficient” according to new report

Categories: TBThe global tuberculosis response and TB research and development remain weak and inadequate despite approval of the first new TB drugs in decades and a new global strategy to reduce TB incidence and mortality, according to Treatment Action Groups’ latest report. With just $255 million spent on TB research and development each year, funding is […](Read more…)

world-health-day-image

Accelerating an Integrated Approach to NCD Prevention and Control Globally

Dr. Samira Asma, Chief, Global NCD Program, CDC Over the past 18 years, I’ve worked with Ministries of Health and other partners in 180 countries to advance CDC’s overarching global health goals and accelerate strategies for the prevention and control of noncommunicable diseases (NCDs) and injuries. NCDs and injuries are responsible for millions of premature deaths, especially in low- and middle-income counties (LMICs). As public health practitioners, we have an important opportunity to work collaboratively to accelerate and scale up implementation of proven prevention and treatment strategies and measure their impact.

Image pmed.1001403.blog_.jpg

U.S. Must Increase Capacity For Global Health R&D, Anticipate Global Disease Threats

Washington Post: Why aren’t we producing medications for looming global disease threats? Mel Spigelman, physician and president and chief executive of TB Alliance “…[A new Global Health Technologies Coalition] analysis reveals that over the past six years, [U.S.] taxpayer funding for global health research has been stagnant or declining. … Managing health threats through emergency…More

Latest

Study Calls For Integration Of Anti-Smoking Strategies Into TB, HIV Care

VOA News: Study: Anti-smoking Strategies Critical to TB and HIV Care “…The International Union Against Tuberculosis and Lung Disease released a report recently arguing that second-hand smoke must be addressed in the treatment of patients with TB and HIV. The research identifies a critical missed opportunity in TB and HIV programs: smoking and exposure to…More


DW Profiles German Biotech CureVac’s Work To Develop Vaccines, Funding From Philanthropic…

Deutsche Welle: Cash injection spurs vaccination hopes “The Bill & Melinda Gates Foundation has invested tens of millions in German biotech firm CureVac. The cash injection will help the company continue working on developing effective vaccines for diseases, including Ebola, HIV, and tuberculosis…” (Meyer, 8/25).


Global Health Community Should Implement Better Screening To Curb Diabetes-TB Comorbidity

Health Affairs Blog: Heading Off The Looming Diabetes-Tuberculosis Epidemic Anthony Harries, senior adviser and director of the Department of Research at the International Union Against Tuberculosis and Lung Disease, discusses the relationship between TB and diabetes as comorbidities and urges the global health community to implement bidirectional screening, which “requires that any patient that tests…More


Blog Posts Highlight Efforts On TB Prevention, Treatment, R&D

Center for Global Health Policy’s “Science Speaks”: Senators call on White House for bold TB Action Plan Rabita Aziz, policy research coordinator for the Center for Global Health Policy, notes, “With the deadline for submitting a national action plan to combat multidrug-resistant tuberculosis quickly approaching, a group of Senators has sent a letter to the…More


Senators call on White House for bold TB Action Plan

Categories: Drug Resistance, TBWith the deadline for submitting a national action plan to combat multidrug-resistant tuberculosis quickly approaching, a group of Senators has sent a letter to the White House applauding the Obama Administration on taking steps to combat the disease that kills more than 4,000 people every day. The plan – due to the White House on […](Read more…)


Tuberculosis R&D “grossly insufficient” according to new report

TBWEB

Categories: TBThe global tuberculosis response and TB research and development remain weak and inadequate despite approval of the first new TB drugs in decades and a new global strategy to reduce TB incidence and mortality, according to Treatment Action Groups’ latest report. With just $255 million spent on TB research and development each year, funding is […](Read more…)


Accelerating an Integrated Approach to NCD Prevention and Control Globally

world-health-day-image

Dr. Samira Asma, Chief, Global NCD Program, CDC Over the past 18 years, I’ve worked with Ministries of Health and other partners in 180 countries to advance CDC’s overarching global health goals and accelerate strategies for the prevention and control of noncommunicable diseases (NCDs) and injuries. NCDs and injuries are responsible for millions of premature deaths, especially in low- and middle-income counties (LMICs). As public health practitioners, we have an important opportunity to work collaboratively to accelerate and scale up implementation of proven prevention and treatment strategies and measure their impact.


Stakeholders Begin To Examine Funding Needs To Prevent, Treat Global Hepatitis Infections

Devex: Where should money go to manage global health’s ‘silent epidemic’? “…Unlike other diseases like HIV and AIDS and tuberculosis — which would need an estimated $22 billion to $24 billion, and $8 billion, respectively, according to statistics released by relevant stakeholders — hepatitis does not yet have a ballpark estimate attached to it. But…More


Fully Funded Phase 4 Trials Necessary To Fill Knowledge Gaps On Malaria Vaccine Effectiveness

BBC News: Malaria vaccine: How good is good enough? Seth Berkely, CEO of Gavi, the Vaccine Alliance, and Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria “How effective does a vaccine have to be before it should be made available? … Such is the question World Health Organization (WHO)…More


Ambitious new U.S. plan may put hundreds of thousands on MDR-TB treatment

Categories: Research and Development, TB, U.S. Policy and FundingThe United States plans to place 360,000 multidrug-resistant tuberculosis patients globally on treatment over the next five years, as part of a national tuberculosis action plan currently under draft. The plan – which is due to be submitted to the White House in September – aims to promote universal MDR-TB treatment, accelerate basic TB research, […](Read more…)


Successes in HIV Overshadow Failures in TB

The world is celebrating a giant milestone in the fight against HIV: 15 million people are now on lifesaving treatment using highly effective antiretroviral drugs! It’s a huge win for global health, and of course for the millions whose lives have been saved.


UNITAID Chair Discusses Innovative Financing In Forbes Interview

Forbes: U.N. Undersecretary Pioneers Invisible Way To End Poverty “U.N. Undersecretary Philippe Douste-Blazy has been on a mission to help people around the world who are suffering beyond comprehension. His UNITAID organization has made material progress raising over $2 billion through micro-levies on airlines tickets that have gone to fight HIV-AIDS, tuberculosis, and malaria. His…More


‘More Pragmatic’ Steps Needed To Reduce TB Risks Among International Travelers

Huffington Post: In The Age Of Travel, Tuberculosis Knows No Borders Sarabjit Chadha, project director at The Union South East Asia; Jamie Tonsing, director at The Union South East Asia; and Paula Fujiwara, scientific director at The Union France “…The risk of [tuberculosis (TB)] transmission during air travel is expected to rise as the number…More


U.S. Secretary Of State Kerry Provides Strong Leadership Critical To Sustaining Global Health…

Huffington Post: The Next Phase of an American Legacy: John Kerry, Global Health, and Financing for Development Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria “…In highlighting U.S. [global health] impact, a common, rarely explored thread emerges: how John Kerry’s steadfast leadership and commitment to global health has significantly…More


Older Posts »